Olipop's Latest Valuation Soars to $1.85 Billion

On Wednesday, Olipop, a soda brand specializing in prebiotic beverages, announced an impressive valuation of $1.85 billion following its recent funding round that brought in $50 million.

Since its establishment in 2018, Olipop has significantly contributed to the prebiotic soda trend, sharing the limelight with competitor Poppi. Both brands have gained popularity by promoting the gut health benefits of their beverages, tapping into a growing consumer interest in health-focused products.

The company's Series C round was spearheaded by J.P. Morgan Private Capital's Growth Equity Partners. The injection of capital will be directed towards broadening Olipop's product range, enhancing its marketing efforts, and expanding distribution channels to increase the reach of its sodas.

Market Position and Consumer Base

Olipop currently stands as the leading non-alcoholic drink brand in the United States when measured by revenue and sales growth, as reported by the company using Circana/SPINS data. With equal contributions from traditional soda consumers and newcomers to the carbonated drinks market, Olipop has captured the interest of one out of every four Gen Z individuals.

Having achieved profitability at the beginning of 2024, Olipop's annual revenue exceeded $400 million last year, marking a two-fold increase from the previous year. It's noteworthy that in 2023, Olipop's CEO Ben Goodwin disclosed that major soda companies PepsiCo and Coca-Cola had expressed interest in a potential acquisition.

Competitor Landscape: Poppi

On the other hand, Poppi, another player in the prebiotic soda space founded a decade ago, has amassed $39.3 million in funding by 2023 according to Pitchbook, though its valuation remains undisclosed. Poppi reported annual sales of over $100 million in 2023 and notably featured in the Super Bowl advertising slot for the second year running.

However, Poppi has faced criticism and legal challenges regarding the health claims associated with their drinks. Ongoing legal discussions aim to resolve allegations that their beverages may not be as beneficial as advertised.